Impact of pharmacy outreach services on blood pressure management in the elderly community of Hong Kong

Geriatrics and Gerontology International

Volumn 13, Issue 1, 2013, Pages 175-181

  Lee, Vivian W Y ^a   Yi, Pang Tin ^b   Kong, Kathy W Y ^c   Chan, Peter K H ^d   Kwok, Fanny L M ^e  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b KWONG WAH HOSPITAL   (Hong Kong)

^c TUEN MUN HOSPITAL   (Hong Kong)

^d PRINCESS MARGARET HOSPITAL   (Hong Kong)

^e KOWLOON HOSPITAL   (Hong Kong)

Author keywords

Clinical pharmacy; Community outreach; Disease knowledge; Elderly; Hypertension

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET; FEMALE; HONG KONG; HUMAN; HYPERTENSION; KNOWLEDGE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; COMMUNITY PHARMACY SERVICES; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84871983914     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2012.00881.x     Document Type: Article

References (29)

1. Hospital Authority, Hong Kong. Hospital Authority statistical report 2009/2010. 2010. [Cited 3 Jun 2010.] Available from URL: http://www.dh.gov.hk/english/statistics/statistics_hs/files/Health_Statistics_pamphlet_E.pdf
2. Centre for Health Protection. Number of deaths by leading causes of death by sex by age in 2010. 2010. [Cited 3 Jun 2010.] Available from URL: http://www.chp.gov.hk/en/data/4/10/27/340.html.
3. Lawes C, Rodgers A, Bennett D etal. Asia Pacific cohort studies collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707-716.
4. Ng MS, Ho KM, Poon TK etal. A retrospective study of patterns and outcomes of A&E department referrals from a family medicine training centre. HK Pract 2009; 31: 7-13.
5. Chan L, Tsui PN, Ng YS etal. Management of hypertension in general out patient clinics (GOPCs) of New Territories west cluster: yesterday, today and tomorrow. HK Pract 2007; 29: 470-480.
6. Cheung MK, Chow CK, Yip CK etal. Poorly controlled diabetes mellitus- what are their characteristics? Paper presented at The Hong Kong College of Family Physicians Annual Scientific Meeting 2008 in Hong Kong, 24 May 2008.
7. Hospital Authority, Hong Kong. Overview of health care services in Hong Kong. 2010. [Cited 25 Apr 2010.] Available from URL: http://www.ha.org.hk/corpinfo/ha/english/helcare.htm#extended.
8. Chung KH, Law LT, Lee VWY. Clinical impact of pharmacist outreach service in community elderly patients. Paper presented at The Chinese University of Hong Kong. May 16, 2008.
9. Chobanian AV, Bakris GL, Black HR etal. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289 (19): 2560-2572.
10. El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit 2003; 8 (3): 127-133.
11. dabl® Educational Trust [Internet]. Co Dublin: dabl® Educational Trust Ltd. 2008. Declaration of blood pressure measuring device equivalence 2006. [about 12 screens]. [Cited 19 Apr 2010.] Available from URL: http://www.dableducational.org/pdfs/equivalence_declarations/E13%20Omron%20IA2%20ESH-BHS.pdf.
12. O'Brien E, Petrie J, Littler WA etal. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11 (Suppl 2): S43-S63.
13. Association for the Advancement of Medical Instrumentation. American national standard. Electronic or automated sphygmomanometers. ANSI/AAMI SP 10-1992. Arlington, VA: AAMI, 1993; 40.
14. Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit 2006; 11 (1): 27-32.
15. Martins D, Gor D, Teklehaimanot S etal. High blood pressure knowledge in an urban African-American community. Ethn Dis 2001; 11: 90-96.
16. Machado M, Bajcar J, Guzzo GC etal. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41: 1770-1781.
17. Deborah PW, Eva MV. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 2008; 28 (4): 421-436.
18. Lee VWY, Chung NKH, Law SLT. Clinical impact of pharmacy outreach service in community elderly patients. Paper Presented at the Chinese University of Hong Kong, May 16 2008.
19. Lee JK, Grace KA, Taylor A. Effect of a pharmacy care program on medication adherence and persistence blood pressure and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006; 296 (21): 2563-2571.
20. Green BB, Cook AJ, Ralston JD etal. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA 2008; 299 (24): 2857-2867.
21. Machado M, Bajcar J, Guzzo GC etal. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41 (11): 1770-1781.
22. Franklin SS, Gustin W, Wong ND etal. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96 (1): 308-315.
23. Franklin SS, Jacobs MJ, Wong ND etal. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37 (3): 869-874.
24. Lee WY, Chan HW, Ko TL etal. Clinical outcome of hypertension management: a 5-year observational study in Hong Kong. J Med Econ 2008; 11: 101-118.
25. Pollitt RA, Rose KM, Kaufman JS. Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review. BMC Public Health 2005; 5: 7-20.
26. Anderson KM, Odell PM, Wilson PWF etal. Cardiovascular disease risk profiles. Am Heart J 1990; 121: 293-298.
27. Elmer PJ, Obarzanek E, Vollmer WM etal. Effects of comprehensive lifestyle modification on diet, weight, physical fitness and blood pressure control: 18 month results of a randomized trial. Ann Intern Med 2006; 144: 485-495.
28. Chan JCW, Siu SC, Wong CKW, Lee VWY. A pharmacist care programme: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther 2012; 17: 57-64.
29. Chung JS, Lee KKC, Tomlinson B, Lee VWY. Clinical and economic impact of clinical pharmacy services on hyperlipidaemic management in Hong Kong. J Cardiovasc Pharmacol Ther 2010; 16 (1): 43-52.